Montreal – September 7, 2018. Zoetis Canada announces that Draxxin® (tulathromycin) Injectable
Solution has received approval from Health Canada for the treatment of ovine foot rot associated with
Dichelobacter nodosus when systematic treatment is required due to the presence of active lesions.
Foot rot, which is caused when the bacteria Dichelobacter nodosus infects the horn of the sheep’s hoof,1
is highly contagious and has serious implications, such as lameness and reduced production.
